search
Back to results

Impact of Nerve-sparing Radical Hysterectomy on Patients' Urinary Dynamics

Primary Purpose

Cervical Cancer, Urinary Retention

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
BiClamp group
water jet group
Sponsored by
Peking Union Medical College Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cervical Cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • FIGO stage IB
  • ASA score 0-2

Exclusion Criteria:

  • Radiotherapy or chemotherapy before surgeries
  • ASA score > 2
  • With abnormal urinary dynamics before surgeries

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Placebo Comparator

    Active Comparator

    Arm Label

    BiClamp group

    water jet group

    Arm Description

    BiClamp forcep (BiClamp® forcep, ERBE Elektromedizin, GmbH, Tuebingen, Germany) is used to dissect inferior hypogastric plexus

    water jet (ERBEJET®2, ERBE Elektromedizin, GmbH, Tuebingen, Germany) is used to dissect inferior hypogastric plexus

    Outcomes

    Primary Outcome Measures

    successful rate of removing urinary catheter
    successful rate (%) of removing urinary catheter assessed by residual urine volume less than 100 ml

    Secondary Outcome Measures

    urinary dynamics parameters determined by urodynamics apparatus: bladder capacity and sensation
    bladder capacity and sensation in ml
    urinary dynamics parameters determined by urodynamics apparatus: residual urine volume
    residual urine volume in ml
    urinary dynamics parameters determined by urodynamics apparatus: urine flow rate
    urine flow rate in ml/s
    urinary dynamics parameters determined by urodynamics apparatus: bladder pressure
    bladder pressure in cmH2O
    urinary dynamics parameters determined by urodynamics apparatus: detrusor pressure
    detrusor pressure in cmH2O
    urinary dynamics parameters determined by urodynamics apparatus: bladder compliance
    bladder compliance in ml/cmH2O
    survival outcomes: ovarall survival
    overall survival in months
    survival outcomes: progression-free survival
    progression-free survival in months

    Full Information

    First Posted
    January 11, 2017
    Last Updated
    January 12, 2017
    Sponsor
    Peking Union Medical College Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03020238
    Brief Title
    Impact of Nerve-sparing Radical Hysterectomy on Patients' Urinary Dynamics
    Official Title
    Impact of Nerve-sparing Radical Hysterectomy on Patients' Urinary Dynamics: a Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2017
    Overall Recruitment Status
    Completed
    Study Start Date
    January 2013 (undefined)
    Primary Completion Date
    January 2016 (Actual)
    Study Completion Date
    January 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Peking Union Medical College Hospital

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Background: Radical hysterectomy is an important therapy for early cervical cancer. Disfunction of urinary dynamics is the most common postoperative adverse effects, which had negative impact on patients' quality of life. Nerve sparing radical hysterectomy (NSRH) could reserve inferior hypogastric plexus (IHP) innervating bladder, hence improving postoperative urinary dynamics. Furthermore impact of different energy instruments on urinary dynamic isn't clear. Objectives: This study is to compare urinary dynamics before and after NSRH, and to analyze the difference between BiClamp forcep (BiClamp® forcep, ERBE Elektromedizin, GmbH, Tuebingen, Germany) and water jet (ERBEJET®2) about the effects of dissecting IHP. Study population: Cervical cancer of FIGO IB stage, among which 120 cases are enrolled to randomly allocated to BiClamp group or water jet group. Intervention: Patients accept NSRH which all will be accomplished by Professor Ming Wu. Methods: All surgical patients are accessed via urinary dynamics before and four months after NSRH. On the 14th day after surgeries, urinary catheter will be removed and residual urine volume (RUV) will be measured. For patients of RUV > 100 ml, urinary catheter will be replaced. Primary study endpoint: the successful rate of removing urinary catheter on the 14th day after NSRH. Secondary study endpoint: urinary dynamics four months after NSRH.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cervical Cancer, Urinary Retention

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Factorial Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    120 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    BiClamp group
    Arm Type
    Placebo Comparator
    Arm Description
    BiClamp forcep (BiClamp® forcep, ERBE Elektromedizin, GmbH, Tuebingen, Germany) is used to dissect inferior hypogastric plexus
    Arm Title
    water jet group
    Arm Type
    Active Comparator
    Arm Description
    water jet (ERBEJET®2, ERBE Elektromedizin, GmbH, Tuebingen, Germany) is used to dissect inferior hypogastric plexus
    Intervention Type
    Procedure
    Intervention Name(s)
    BiClamp group
    Other Intervention Name(s)
    BiClamp® forcep, ERBE Elektromedizin
    Intervention Description
    electric energy
    Intervention Type
    Procedure
    Intervention Name(s)
    water jet group
    Other Intervention Name(s)
    ERBEJET®2, ERBE Elektromedizin
    Intervention Description
    water jet energy
    Primary Outcome Measure Information:
    Title
    successful rate of removing urinary catheter
    Description
    successful rate (%) of removing urinary catheter assessed by residual urine volume less than 100 ml
    Time Frame
    14th day after nerve-sparing radical hysterectomy
    Secondary Outcome Measure Information:
    Title
    urinary dynamics parameters determined by urodynamics apparatus: bladder capacity and sensation
    Description
    bladder capacity and sensation in ml
    Time Frame
    four months after nerve-sparing radical hysterectomy
    Title
    urinary dynamics parameters determined by urodynamics apparatus: residual urine volume
    Description
    residual urine volume in ml
    Time Frame
    four months after nerve-sparing radical hysterectomy
    Title
    urinary dynamics parameters determined by urodynamics apparatus: urine flow rate
    Description
    urine flow rate in ml/s
    Time Frame
    four months after nerve-sparing radical hysterectomy
    Title
    urinary dynamics parameters determined by urodynamics apparatus: bladder pressure
    Description
    bladder pressure in cmH2O
    Time Frame
    four months after nerve-sparing radical hysterectomy
    Title
    urinary dynamics parameters determined by urodynamics apparatus: detrusor pressure
    Description
    detrusor pressure in cmH2O
    Time Frame
    four months after nerve-sparing radical hysterectomy
    Title
    urinary dynamics parameters determined by urodynamics apparatus: bladder compliance
    Description
    bladder compliance in ml/cmH2O
    Time Frame
    four months after nerve-sparing radical hysterectomy
    Title
    survival outcomes: ovarall survival
    Description
    overall survival in months
    Time Frame
    two years after nerve-sparing radical hysterectomy
    Title
    survival outcomes: progression-free survival
    Description
    progression-free survival in months
    Time Frame
    two years after nerve-sparing radical hysterectomy

    10. Eligibility

    Sex
    Female
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: FIGO stage IB ASA score 0-2 Exclusion Criteria: Radiotherapy or chemotherapy before surgeries ASA score > 2 With abnormal urinary dynamics before surgeries
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Wu Ming, MD
    Organizational Affiliation
    Peking Union Medical College Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Yes
    IPD Sharing Plan Description
    IPD will be shared with authorised researchers via online database.

    Learn more about this trial

    Impact of Nerve-sparing Radical Hysterectomy on Patients' Urinary Dynamics

    We'll reach out to this number within 24 hrs